Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Potere Health MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Potere Health MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 296 · Grade C

Potere Health MD

Visit Potere Health MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Potere Health MD a bad call — it's best for utah residents who want a named local physician and can confirm the vial, total charge and usable supply before paying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
77
Transparency
90
48
Access Breadth
93
56
Clinical Oversight
92
87
Track Record
88
82
CoreAge RxBrief Score 94 · 64Potere Health MD

Price, coverage & the tracker

CoreAge RxPotere Health MD
Brief Score94/100 (A)64/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

10 mg vial: $239 / $239.99 shown

Full upfront vial charge, not monthly installments. Usable duration depends on prescribed dose and pharmacy use-by instructions.

Care and supplies included in advertised program; cents and larger-vial refill tables differ. Exact selected quote unconfirmed.

Full price details

Compounded semaglutide offered; complete selected-supply quote unknown; homepage lists $239 for a 10 mg vial while pricing examples show $239.99; duration depends on dose and pharmacy use-by instructions

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$119 for four-week starter option

Homepage: 10 mg vial, 2.5 mg weekly for four weeks. Larger 60 mg option shown at $350 upfront.

Larger-vial refill tables disagree; dose, usable supply and exact selected charge need confirmation.

Full price details

Compounded tirzepatide offered; complete selected-supply quote unknown; homepage lists $119 per four weeks at 2.5 mg weekly or $350 for a 60 mg vial; pricing FAQ also lists different larger-vial refill charges

CoverageUS only; restrictions by state, confirmed at intakeIn-person clinics and telehealth throughout Utah; other-state treatment eligibility unconfirmed
Brand-name accessNot confirmedZepbound and Wegovy options are advertised separately from compounded programs; product eligibility and pharmacy pricing require confirmation.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Potere Health MD: Vial-based program: confirm the exact upfront payment, supply and pharmacy use-by limit. Larger tirzepatide refill tables disagree; do not treat starter monthly estimates as ongoing costs.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.